Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 6—June 2005
Research

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States

Kurt B. Stevenson*†Comments to Author , Katy Searle†, Gregory Stoddard†, and Matthew H. Samore†‡
Author affiliations: *Qualis Health, Boise, Idaho, USA; †University of Utah School of Medicine, Salt Lake City, Utah, USA; ‡VA Salt Lake City Health Care System, Salt Lake City, Utah, USA

Main Article

Table 3

Comparison of antimicrobial susceptibilities by category

Agent No. susceptible (%) p value†
HA-MRSA CA-MRSA with CFs CA-MRSA without CFs
Oxacillin 0/204 (0) 0/34 (0) 0/106 (0) NS
Erythromycin 10/193 (5) 3/34 (9) 16/98 (16) 0.007
Clindamycin 42/195 (22) 11/34 (32) 61/100 (61) <0.0001
Ciprofloxacin 9/138 (7) 2/19 (11) 23/73 (32) <0.0001
Gentamicin 196/204 (96) 33/34 (97) 99/105 (94) NS
Trimethoprim-sulfamethoxazole 202/203 (99) 34/34 (100) 102/106 (96) NS
Rifampin 157/166 (95) 23/24 (96) 79/82 (96) NS
Tetracycline 183/190 (96) 25/27 (93) 93/101 (92) NS
Vancomycin 203/203 (100) 33/33 (100) 105/106 (99)‡ NS

*HA, healthcare-associated; MRSA, methicillin-resistant Staphylococcus aureus; CA, community-associated; CFs, coexisting factors; NS, not significant.
†Based on Fisher exact test.
‡One isolate reported as vancomycin resistant. Isolate not available for confirmatory testing.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external